Anette Küster

German Environment Agency — Germany

Environmental Science · Physical Sciences

15h-index2.8kcitations28works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pharmaceutical and Antibiotic Environmental Impacts(11), Environmental Toxicology and Ecotoxicology(5), Algal biology and biofuel production(4), Helminth infection and control(4), Agricultural safety and regulations(4)

Publications28 total

Berlin statement on legacy and emerging contaminants in polar regions
Chemosphere·2023· 12 citedOpen Access
Berlin Statement on Legacy and Emerging Contaminants in Polar Regions
SSRN Electronic Journal·2023Open Access
Experiences of the German Environment Agency in Sharing Data Via IPCHEM for Further Improving Human Health and Protecting the Environment
ISEE Conference Abstracts·2018· 1 cited
Pharmaceuticals in the environment—Global occurrences and perspectives
Environmental Toxicology and Chemistry·2015· 1.4k cited
<i>In Response</i>: A regulatory perspective on prioritization of emerging pollutants in the context of the Water Framework Directive
Environmental Toxicology and Chemistry·2015· 8 cited
Pharmaceuticals in the environment: scientific evidence of risks and its regulation
Philosophical Transactions of the Royal Society B Biological Sciences·2014· 353 citedOpen Access
The international environmental specimen banks—let’s get visible
Environmental Science and Pollution Research·2014· 15 cited
Toxicity of the fluoroquinolone antibiotics enrofloxacin and ciprofloxacin to photoautotrophic aquatic organisms
Environmental Toxicology and Chemistry·2011· 267 cited
A non-invasive observation parameter to complement sediment bioassays using Myriophyllum aquaticum
Journal of Soils and Sediments·2011· 3 cited
Using the fish plasma model for comparative hazard identification for pharmaceuticals in the environment by extrapolation from human therapeutic data
Regulatory Toxicology and Pharmacology·2011· 61 cited
Reporting and evaluation criteria as means towards a transparent use of ecotoxicity data for environmental risk assessment of pharmaceuticals
Environmental Pollution·2011· 55 cited
Erratum: Environmental risk assessment of ivermectin: A case study
Integrated Environmental Assessment and Management·2010· 2 cited
Environmental risk assessment of ivermectin: A case study
Integrated Environmental Assessment and Management·2010· 164 citedOpen Access
Environmental risk assessment for the serotonin re-uptake inhibitor fluoxetine: Case study using the European risk assessment framework
Integrated Environmental Assessment and Management·2010· 96 cited
Evaluation du risque environnemental des substances pharmaceutique dans l'Union Européenne : étude du cas du beta-bloquant Atenolol
HAL (Le Centre pour la Communication Scientifique Directe)·2010· 4 cited
Environmental risk assessment of human pharmaceuticals in the European Union: A case study with the β-blocker atenolol
Integrated Environmental Assessment and Management·2009· 100 citedOpen Access
Models for extrapolation of long-term effects of pharmaceuticals in the environment using therapeutic information
Toxicology Letters·2009
The CHMP guideline on environmental risk assessment of medicinal products for human use: Three years of regulatory experience
Toxicology Letters·2009· 16 cited
Regulatory demands on data quality for the environmental risk assessment of pharmaceuticals
Regulatory Toxicology and Pharmacology·2009· 39 cited
Environmental risk assessment of ivermectin. A case study with a veterinary pharmaceutical
2008
page 1 of 2Next →

Frequent Co-authors

Jeanne Garric(8), Kathrin Fenner(7), Thomas Knacker(7), Jörg Römbke(5), Anne Wehrhan(5), Bettina Rechenberg(5), Rolf Altenburger(5), Ina Ebert(4), Philipp Egeler(4), Thomas A. Ternes(4), Karen Duis(4), Beate I. Escher(4), Silke Hickmann(3), Jean Bachmann(3), Carola Kussatz(3), Alistair B.A. Boxall(3), Guido Fink(3), Bent Halling‐Sørensen(3), Kristine A. Krogh(3), Manuel K. Schneider(3)